Indices
KSE100 173939.01 ↑ 4027.06 (2.32%) ALLSHR 103800.94 ↑ 2426.33 (2.34%) KSE30 52809.96 ↑ 1336.80 (2.53%) KMI30 250755.67 ↑ 4699.36 (1.87%) BKTI 48513.81 ↑ 1916.74 (3.95%) OGTI 36285.57 ↑ 1083.83 (2.99%) KMIALLSHR 67535.39 ↑ 1339.91 (1.98%) JSGBKTI 74046.40 ↑ 3027.28 (4.09%) MII30 22636.82 ↑ 365.22 (1.61%) KSE100PR 53622.88 ↑ 1239.26 (2.31%) KSE100 173939.01 ↑ 4027.06 (2.32%) ALLSHR 103800.94 ↑ 2426.33 (2.34%) KSE30 52809.96 ↑ 1336.80 (2.53%) KMI30 250755.67 ↑ 4699.36 (1.87%) BKTI 48513.81 ↑ 1916.74 (3.95%) OGTI 36285.57 ↑ 1083.83 (2.99%) KMIALLSHR 67535.39 ↑ 1339.91 (1.98%) JSGBKTI 74046.40 ↑ 3027.28 (4.09%) MII30 22636.82 ↑ 365.22 (1.61%) KSE100PR 53622.88 ↑ 1239.26 (2.31%)
Pharmaceutical giant GlaxoSmithKline Pakistan Limited announced on Tuesday the appointment of Dmytro Oliinyk,

FaceBook

Whatsapp

Twitter

Comment

GSK Pakistan appoints chairperson

Pharmaceutical giant GlaxoSmithKline Pakistan Limited announced on Tuesday the appointment of Dmytro Oliinyk, VP Head of Finance, International Region of GlaxoSmithKline, as Non-Executive Director and Chairperson.

The company disclosed in a notice to the Pakistan Stock Exchange (PSX) today.

It said that Dmytro will fill in the casual vacancy due to the resignation of Lai Kuen Goh from the Board of Directors of GlaxoSmithKline Pakistan Limited.

GlaxoSmithKline Pakistan Limited was incorporated in Pakistan as a limited liability company and is engaged in the manufacturing and marketing of research-based ethical specialities and pharmaceutical products.

The company is a subsidiary of S.R. One International B.V., incorporated in the Netherlands, whereas its ultimate parent company is GlaxoSmithKline plc, UK (GSK plc)

Send Us A Message